DE1598886B2 - Verfahren zur Durchführung immunserologischer Reaktionen - Google Patents
Verfahren zur Durchführung immunserologischer ReaktionenInfo
- Publication number
- DE1598886B2 DE1598886B2 DE19651598886 DE1598886A DE1598886B2 DE 1598886 B2 DE1598886 B2 DE 1598886B2 DE 19651598886 DE19651598886 DE 19651598886 DE 1598886 A DE1598886 A DE 1598886A DE 1598886 B2 DE1598886 B2 DE 1598886B2
- Authority
- DE
- Germany
- Prior art keywords
- blood cells
- red
- blood
- cells
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000006243 chemical reaction Methods 0.000 title claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 19
- 210000003743 erythrocyte Anatomy 0.000 claims description 19
- 210000002966 serum Anatomy 0.000 claims description 15
- 230000004520 agglutination Effects 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- 210000004027 cell Anatomy 0.000 claims description 9
- 150000002500 ions Chemical class 0.000 claims description 9
- 229920001282 polysaccharide Polymers 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229960004793 sucrose Drugs 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000000084 colloidal system Substances 0.000 claims description 6
- 239000012429 reaction media Substances 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 229920002307 Dextran Polymers 0.000 claims description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 230000007423 decrease Effects 0.000 claims description 3
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229920003169 water-soluble polymer Polymers 0.000 claims description 2
- 210000000601 blood cell Anatomy 0.000 claims 5
- 102000035195 Peptidases Human genes 0.000 claims 3
- 108091005804 Peptidases Proteins 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 150000001768 cations Chemical class 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 206010067122 Haemolytic transfusion reaction Diseases 0.000 claims 1
- 101100400378 Mus musculus Marveld2 gene Proteins 0.000 claims 1
- 208000003441 Transfusion reaction Diseases 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 238000009534 blood test Methods 0.000 claims 1
- 230000036760 body temperature Effects 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 230000005611 electricity Effects 0.000 claims 1
- 239000003792 electrolyte Substances 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 108010074605 gamma-Globulins Proteins 0.000 claims 1
- 230000035931 haemagglutination Effects 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 125000003010 ionic group Chemical group 0.000 claims 1
- 239000010871 livestock manure Substances 0.000 claims 1
- 230000005906 menstruation Effects 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229920000867 polyelectrolyte Polymers 0.000 claims 1
- 239000003223 protective agent Substances 0.000 claims 1
- 238000004062 sedimentation Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 8
- 239000003085 diluting agent Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000006471 dimerization reaction Methods 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009582 blood typing Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36899864A | 1964-05-20 | 1964-05-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE1598886A1 DE1598886A1 (de) | 1970-07-30 |
| DE1598886B2 true DE1598886B2 (de) | 1974-03-14 |
| DE1598886C3 DE1598886C3 (enExample) | 1975-12-04 |
Family
ID=23453634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19651598886 Granted DE1598886B2 (de) | 1964-05-20 | 1965-05-11 | Verfahren zur Durchführung immunserologischer Reaktionen |
Country Status (11)
| Country | Link |
|---|---|
| BE (1) | BE664165A (enExample) |
| BR (1) | BR6569756D0 (enExample) |
| CH (1) | CH480633A (enExample) |
| DE (1) | DE1598886B2 (enExample) |
| DK (1) | DK115892B (enExample) |
| ES (1) | ES313023A1 (enExample) |
| FR (1) | FR1464603A (enExample) |
| GB (1) | GB1086271A (enExample) |
| IL (1) | IL23537A (enExample) |
| NL (1) | NL6506461A (enExample) |
| SE (1) | SE340673B (enExample) |
-
1965
- 1965-05-11 DE DE19651598886 patent/DE1598886B2/de active Granted
- 1965-05-14 GB GB2043765A patent/GB1086271A/en not_active Expired
- 1965-05-14 IL IL2353765A patent/IL23537A/xx unknown
- 1965-05-17 ES ES0313023A patent/ES313023A1/es not_active Expired
- 1965-05-17 DK DK247765A patent/DK115892B/da unknown
- 1965-05-18 SE SE647765A patent/SE340673B/xx unknown
- 1965-05-18 CH CH691165A patent/CH480633A/de not_active IP Right Cessation
- 1965-05-19 BE BE664165A patent/BE664165A/xx unknown
- 1965-05-19 BR BR16975665A patent/BR6569756D0/pt unknown
- 1965-05-19 FR FR17627A patent/FR1464603A/fr not_active Expired
- 1965-05-20 NL NL6506461A patent/NL6506461A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1598886A1 (de) | 1970-07-30 |
| BE664165A (enExample) | 1965-11-19 |
| NL6506461A (enExample) | 1965-11-22 |
| IL23537A (en) | 1969-03-27 |
| BR6569756D0 (pt) | 1973-07-26 |
| CH480633A (de) | 1969-10-31 |
| GB1086271A (en) | 1967-10-04 |
| DK115892B (da) | 1969-11-17 |
| DE1598886C3 (enExample) | 1975-12-04 |
| ES313023A1 (es) | 1965-12-16 |
| FR1464603A (fr) | 1967-01-06 |
| SE340673B (enExample) | 1971-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2008493C3 (de) | Hämatologische Kontrollflüssigkeit | |
| DE2450523B2 (de) | Verfahren zum immunologischen nachweis von proteinen | |
| DE2707881C2 (de) | Verfahren zum Nachweis von rheumatoiden Faktoren | |
| DD202178A5 (de) | Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen | |
| DE69716046T2 (de) | Methode zur erkennung von heparin-induzierter thrombozytopenie | |
| DE2651139A1 (de) | Reagens zur durchfuehrung eines direktagglutinationstests zum schwangerschaftsnachweis und verfahren zu seiner herstellung | |
| DE3034142C2 (enExample) | ||
| DE3105555C2 (enExample) | ||
| Polley et al. | Serological Characteristics of Anti‐A Related to Type of Antibody Protein (7S γ or 19S γ) | |
| DE69200460T2 (de) | Agglutinationskomplex zum Nachweis von Blutgruppen. | |
| CH634150A5 (de) | Immunologisches bestimmungsverfahren. | |
| DE3017707A1 (de) | Verfahren und reagens zum nachweis von fibrinmonomer | |
| DE10029705A1 (de) | Herstellung von IgY(AFc)-Antikörpern und deren Verwendung | |
| EP0311094B1 (de) | Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B | |
| DE2850950C3 (de) | Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren | |
| DE2754350A1 (de) | Verfahren zur bestimmung von antikoerpern, antigenen oder komplexen aus antikoerpern und antigenen in fluessigkeiten | |
| DE3424640C2 (enExample) | ||
| DE2707913C2 (de) | Verfahren zum Nachweis von rheumatoiden Faktoren | |
| DE1598886C3 (enExample) | ||
| EP0579138A1 (de) | Verfahren und Reagenz zur spezifischen Bestimmung von LDL in Serumproben | |
| DE3887727T2 (de) | Partikelstabilisierte Epitope zur Standardisierung und Kontrolle von Immuntests. | |
| DE3024270C2 (de) | Zusammensetzung zur Bestimmung des menschlichen Erythropoietins und Verfahren zu dessen Bestimmung | |
| DE69131431T2 (de) | Verfahren zur Herstellung einer diagnostischen Reagenz für Syphilis | |
| DE3014076A1 (de) | Neue heparin-fraktionen mit erhoehter antikoagulans-wirkung | |
| EP0014965A1 (de) | Immunologisches diagnostisches Reagenz zur Bestimmung der Schwangerschaft, Verfahren zu dessen Herstellung sowie dessen Verwendung zur Bestimmung der Schwangerschaft |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) |